Optimism Grows For Akero Therapeutics (AKRO) As Study Results Spark Stock Rally
Fahim Awan
January 27, 2025
Following the release of the topline preliminary findings from its SYMMETRY Phase 2b research, shares of Akero Therapeutics, Inc. (NASDAQ: AKRO) are seeing a significant